| Literature DB >> 36028271 |
Akaninyene Asuquo Otu1,2, Emmanuel E Effa3,2, Obiageli Onwusaka2,4, Chiamaka Omoyele5, Stella Arakelyan6, Okey Okuzu7, John Walley8.
Abstract
OBJECTIVE: To pilot the use of a scalable innovative mobile health (mHealth) non-communicable diseases (NCDs) training application for nurses at the primary care level.Entities:
Keywords: education & training (see medical education & training); health informatics; public health
Mesh:
Year: 2022 PMID: 36028271 PMCID: PMC9422821 DOI: 10.1136/bmjopen-2021-060304
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 3.006
Logic model table showing intervention inputs, intervention process and intended practice change
| Intervention inputs | Intervention process and actions | Intended | ||
| Practice change | Outputs | Health outcome | ||
|
Case management desk guideline, including lifestyle counselling mHealth training of nurses on the desk guide package Nurse WhatsApp support group Supervision of care visits (quarterly) Digital BP apparatus, glucometer and strips Treatment cards, used for clinical care (subsequently used also as research data records) Monthly funds for health workers’ telecommunication fees |
Screen/diagnose Prescribe antihypertensive Identify hypertension and/or diabetes and treat Counsel for lifestyle modification Follow-up care Focus group discussion with nurses, month 5 | Provider practice: Screen, diagnose, treat, counsel, follow-up and report as per the case management desk guideline Follow-up visits Treatment Lifestyle changes as counselled, e.g., healthy eating, activity, smoking cessation | Patients are: Screened and diagnosed as per desk guide Prescribed right drug/ dose Counselled for life-style change Followed-up and treated, that is, continuing care |
BP trend by visit (primary outcome) Hypertension and/or diabetes care recorded on the NCD card |
BP, blood pressure; NCD, non-communicable disease.
Characteristics of patients with NCDs served by targeted PHC clinics, n=569
| Characteristics | Male (n=206/36%) | Female (n=363/64%) | Total (n=569) |
| Age (µ±SD) | 53.5±15.2 | 49.75±14.2 | 51.8±14.2 |
| Patients with NCD who attended facilities | |||
| Hypertension | 155 (75.2%) | 277 (76.3%) | 432 (75.9%) |
| Diabetes | 23 (11.2%) | 47 (13.0%) | 70 (12.3%) |
| Asthma/COPD | 10 (4.9%) | 17 (4.7%) | 27 (4.7%) |
| Depression | 1 (0.5%) | 8 (2.2%) | 9 (1.6%) |
| Sickle cell anaemia | 6 (3.0%) | 1 (0.3%) | 7 (1.2%) |
| Epilepsy | 3 (1.5%) | 3 (0.8%) | 6 (1.1%) |
| Other NCDs | 8 (3.9%) | 10 (2.8%) | 18 (3.2%) |
| Total | 206 (100%) | 363 (100%) | 569 (100%) |
| New diagnosis of NCDs | |||
| Yes | 145 (70.4%) | 269 (74.2%) | 414 (72.7%) |
| No | 61 (29.6%) | 94 (25.8%) | 155 (27.3%) |
| Total | 206 (100%) | 363 (100%) | 569 (100%) |
| Check-up items | |||
| Height (µ±SD) | 1.56±0.14 | 1.56±0.11 | 1.56±0.12 |
| Weight (µ±SD) | 67.4±12.6 | 68.5±12.4 | 68.1±12.5 |
| BMI | |||
| Normal 18.5–24 | 57 (27.7%) | 114 (31.4%) | 171 (30.0%) |
| Overweight 25–30 | 78 (37.9%) | 124 (34.1%) | 202 (35.5%) |
| Obese ≥30 | 62 (30.1%) | 122 (33.6%) | 184 (32.3%) |
| Total | 206 (100%) | 363 (100%) | 569 (100%) |
| BP | |||
| Normal BP 90/60–120/80 mm Hg | 52 (25.2%) | 73 (20.1%) | 125 (22.7%) |
| High normal 130/85−139/89 mm Hg | 21 (10.2%) | 38 (10.5%) | 59 (10.4%) |
| High BP ≥140/90 mm Hg | 133 (64.6%) | 252 (69.4%) | 385 (67.7) |
| Total | 206 (100%) | 363 (100%) | 569 (100%) |
| Diagnostic tests | |||
| FBS | |||
| Normal reading <5.6 mmol/L | 30 (40.0%) | 56 (40.0%) | 86 (40.0%) |
| Pre-diabetes 5.6–6.9 mmol/L | 15 (20.0%) | 32 (23%) | 47 (21.9%) |
| Diabetes reading >7.0 mmol/L | 30 (40.0%) | 52 (37.1%) | 82 (38.1%) |
| Total | 75 (100%) | 140 (100%) | 215 (100%) |
| Urine analysis | |||
| Normal | 32 (69.6%) | 57 (65.5%) | 89 (66.9%) |
| Proteinuria and/or glycosuria* | 14 (30.4%) | 30 (34.5%) | 44 (33.1%) |
| Total recorded | 46 (100%) | 87 (100%) | 133 (100%) |
*Proteinuria—proteins in urine, glycosuria—sugar in urine. According to the NCD guideline, fasting blood glucose taken if overweight or have related symptoms, and urine analysis as indicated.
BP, blood pressure; COPD, chronic obstructive pulmonary disease; FBS, fasting blood sugar; NCD, non-communicable disease.
Figure 1Gender distribution of newly diagnosed non-communicable disease (NCD) cases. COPD, chronic obstructive pulmonary disease.
Trend on blood pressure from visit 1 to visit 3 based on the average of two measurements
| Parameter | Value | All patients (screening visit) | Patients with 2 visits | patients with 3 visits | ||
| Visit 1 | Visit 2 | Visit 1 | Visit 3 | |||
| Systolic BP (mm Hg) | Valid values | 420 | 230 | 230 | 98 | 98 |
| Mean (±SD) | 159.9 (23.3) | 160.3 (20.7) | 143.2 (20.6) | 162.1 (21.4) | 139.3 (19.1) | |
| Range | 90–270 | 90–220 | 99–218 | 90–220 | 80–180 | |
| Values>140 (%) | 77.6% | 79.6 | 43% | 83.7 | 32.3% | |
| Values>180 (%) | 15.0% | 14.8 | 3.9% | 16.3 | – | |
| Diastolic BP (mm Hg) | Valid values | 420 | 230 | 230 | 98 | 98 |
| Mean (±SD) | 96.0 (14.3) | 95.3 (13.5) | 85.5 (12.3) | 93.8 (15.3) | 81.7 (11.1) | |
| Range | 50–174 | 50–152 | 80–130 | 50–152 | 50–120 | |
| Values>90 (%) | 60.7% | 59.1 | 22.6% | 53.1 | 13.3% | |
| Values>110 (%) | 10.2% | 7.8 | 3.9% | 9.2 | 1.0% | |
BP, blood pressure.
Figure 2Trends in blood pressure (BP) change among patients with hypertension (n=428).
Figure 3Challenges encountered by patients during the period of clinic visits. *Count shows times each barrier was mentioned.